International Society of Amyloidosis (EIN 542153449) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

Mona Johnson

Phone

9526831878

Tax Period

2024-01-01 to 2024-12-31

International Society of Amyloidosis, founded in 2002, is a community nonprofit in the Medical Research sector that reported $2.3M in total revenue in fiscal year 2024. Revenue surged 230% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.7M, a strong 72% operating margin.

Mission

To promote research, education, clinical studies (including diagnosis and treatment), conferences and symposia on all aspects of amyloidosis worldwide.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $554,519

Program Service Revenue $1,711,458

Investment Income $35,949

Other Revenue $0

TOTAL REVENUE $2,301,926

Expense Breakdown

Grants Paid $377,513

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $475,323

Other Expenses $263,938

TOTAL EXPENSES $641,451

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,301,926	$697,376	+2.3%
Expenses	$641,451	$300,698	+1.1%
Net Income	$1,660,475	$396,678	+3.2%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Shaji Kumar	President	2.00	Officer Director	$0	$0	$0
Stefan Schoenland	Past President	2.00	Officer Director	$0	$0	$0
Yoshiki Sekijima	Vice President/President-Elect	2.00	Officer Director	$0	$0	$0
Mathew Maurer	Secretary	1.00	Officer Director	$0	$0	$0
Anita D'Souza	Treasurer	1.00	Officer Director	$0	$0	$0
Efstathios Kastritis	Member at Large	0.50	Director	$0	$0	$0
Lisa Mendelson	Member at Large	0.50	Director	$0	$0	$0
Hironobu Naike	Representative of the Japanese Society	0.50	Director	$0	$0	$0
Maite Teresa Cibeira	Member at Large	0.50	Director	$0	$0	$0
Eloisa Riva	Member at Large	0.50	Director	$0	$0	$0
Giovanni Palladini	Representative of the German Society	0.50	Director	$0	$0	$0
Alexander Carpintiero	Representative of the Italian Society	0.50	Director	$0	$0	$0
Mona Johnson	Executive Director	20.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,301,926	$641,451	$2,489,452	$1,660,475
2023	$697,376	$300,698	$727,899	$396,678
2021	$248,977	$89,134	$355,913	$159,843

International Society of Amyloidosis